Migraine Drugs Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/migraine-drugs-market
Some of the strategies that are majorly being adopted by these players include new products offering, expansion, partnership & collaboration, and mergers & acquisitions among others. For instance, Allergan's Ubrogepant and Eli Lilly's Lasmiditan are the migraine drugs based on the advanced mechanism of action.
In February 2020, Biohaven Pharmaceutical Holding Co. Ltd.'s oral pill known as Nurtec ODT, chemically known as rimegepant was approved by the US FDA. This drug is consumed for dismissing the pain after the onset of migraine headaches. The dug falls under CGRP and directly competes with the first approved Allergan Plc's Ubrelvy.
In December 2019, the migraine drug Ubrogepant (Ubrelvy) manufactured by Allergen Plc has been approved by the US FDA. Ubrogepant is the CGRP drug in tablet form which is meant to be taken immediately after the onset of migraines by adults.
In September 2018, Ajovy, a migraine drug manufactured by Teva Pharmaceutical Industries Ltd. received US regulatory approval. Ajovy is an injectable drug that is to be taken in a few months for relieving migraines in adults.
In May 2018, Aimovig, the drug manufactured by Amgen Inc. received the US FDA approval. The drug is given monthly by self-injection and charges up to $575 monthly in the US. The company manufactured Aimovig in partnership with Novartis International AG, a Swiss multinational pharmaceutical company.
Current Market Trends Covered in the Global Migraine Drug Market Report:
• Increased healthcare spending and improving healthcare infrastructure is influencing the global migraine drugs industry growth during the forecast period.
• Shifting consumer preferences towards the use of injections for a quicker relief is expected to provide ample growth opportunities for market growth.
• The injection segment will account for significant growth in the market.
• The novel drug innovations, various regulatory approvals, and geographical expansions will be the key strategy of the players.
• North America region is expected to hold a prominent share in the migraine drugs market.
Global Migraine Drugs Market - Segmentation
• Acute Migraine Treatment
• Preventive Migraine Treatment
By Route of Administration
• Others (Spray)
A full report of Global Migraine Drugs Market is available at: https://www.omrglobal.com/industry-reports/migraine-drugs-market
Global Migraine Drugs Market - Segmentation by Region
• United States
• United Kingdom
• Rest of Europe
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
• Allergan Plc
• Amgen Inc.
• Astrazeneca PLC
• Bausch Health Companies Inc.
• Biohaven Pharmaceutical Holding Co. Ltd.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly & Co.
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Mylan N.V.
• Novartis International AG
• Neurelis, Inc.
• Pfizer Inc.
• Sanofi SA
Visit More Report at
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029 here
News-ID: 2952083 • Views: 110
More Releases from Orion Market Research
Bluetooth Low Energy (BLE) Beacon Market Share, Trends, Future Outlook, Analysis …
The global Bluetooth Low Energy (BLE) beacon market is expected to grow at a significant CAGR of 26.6% during the forecast period. The major factors contributing to the growth of the global BLE beacon market include rising disposable income and increased demand for proximity marketing. Consumers need some more customized marketing or an advertising strategy to progress toward a purchase in the era of digital marketing concepts. This is known
Breathalyzer Market Share, Trends, Future Outlook, Analysis and Forecast 2023-20 …
The global breathalyzer market is anticipated to grow at a CAGR of around 8.5% during the forecast period. The factors that are augmenting the growth of the global breathalyzer market include increasing alcohol abuse, rising prevalence of diseases such as asthma, CPOD, chronic bronchitis, and emphysema, and increasing deaths due to drink and drive globally. For instance, as per the US Department of Transportation, National Highway Traffic Safety Administration (NHTSA),
Brachytherapy Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2 …
The global brachytherapy market is estimated to grow at a CAGR of 3.5% during the forecast period. Brachytherapy has evolved over the decades owing to a significant transformation in the way that brachytherapy is applied for different treatment locations. This is resulting owing to the development of new treatment delivery techniques and technologically advanced computer planning systems. Advanced 3D imaging modalities have been integrated into treatment planning methods that allow
Bluetooth Tester Market Trends, Segmentation, Growth, Analysis and Forecast 2023 …
The global Bluetooth tester market is projected to exhibit a significant growth, at a CAGR of around 6.0%, during the forecast period. The increasing trend of beacons technology is one of the major factors for the significant growth of the market. Bluetooth Smart also known as BLE (Bluetooth low energy) and in general categorized as beacon technology that is a guiding or warning signal such as a light or a
More Releases for Migraine
Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help